3-((3-cholamidopropyl)dimethylammonium)-1-propanesulfonate has been researched along with Fibrosarcoma in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, MH; Hodge, G; Hua, CT; Isaac, EL; Karageorgos, LE; Litjens, T; Meikle, PJ | 1 |
1 other study(ies) available for 3-((3-cholamidopropyl)dimethylammonium)-1-propanesulfonate and Fibrosarcoma
| Article | Year |
|---|---|
Transthyretin interacts with the lysosome-associated membrane protein (LAMP-1) in circulation.
Topics: Alternative Splicing; Antigens, CD; Blood Proteins; Cell Line, Tumor; Cholic Acids; Fibrosarcoma; Gene Expression Regulation, Neoplastic; Humans; Lysosomal Membrane Proteins; Prealbumin; Protein Isoforms; Recombinant Proteins | 2004 |